Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/6/2018
SIETES contiene 92381 citas

 
 
 1 a 20 de 468 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Patel TK, Patel TB. Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis. Eur J Clin Pharmacol 2018;74:junio. [Ref.ID 102626]
2.Enlace a cita original Cita con resumen
Gershon AS, Campitelli MA, Hawken S, Victor C, Sproule BA, Kurdyak P, Selby P. Cardiovascular and neuropsychiatric events after varenicline use for smoking cessation. Am J Respir Crit Care Med 2018;197:913-22. [Ref.ID 102579]
5. Cita con resumen
Peckham AM, Fairman KA, Sclar DA. Call for increased pharmacovigilance of gabapentin. BMJ 2017;359:j5456. [Ref.ID 102156]
6. Cita con resumen
Miró O, Rosselló X, Gil V, Martín-Sánchez FJ, Llorens P, Herrero-Puente P, Jacob J, Bueno H, Pocock SJ, on behalf of the ICA-SEMES Research Group. Predicting 30-day mortality for patients with acute heart failure in the emergency department: a cohort study. Ann Intern Med 2017;167:698-705. [Ref.ID 102155]
7. Cita con resumen
Tricco AC, Thomas SM, Veroniki AA, Hamid JS, Cogo E, Strifler L, Khan PA, Robson R, Sibley KM, MacDonald H, Riva JJ, Thavorn K, Wilson C, Holroyd-Leduc J, Kerr GD, Feldman F, Majumdar SR, Jaglal SB, Hui W, Straus SE. Comparisons of interventions for preventing falls in older adults. A systematic review and meta-analysis. JAMA 2017;318:1687-99. [Ref.ID 102139]
8. Cita con resumen
Varga S, Alcusky M, Keith SW, Hegarty SE, Del Canale S, Lombardi M, Maio V. Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults. Br J Clin Pharmacol 2017;83:2572-80. [Ref.ID 102117]
9. Cita con resumen
Varga S, Alcusky M, Keith SW, Hegarty SE, Del Canale S, Lombardi M, Maio V. Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults. Br J Clin Pharmacol 2017:4 de agosto. [Ref.ID 102012]
11. Cita con resumen
Ebell MH. WHO downgrades status of oseltamivir. BMJ 2017;358:j3266. [Ref.ID 101981]
12. Cita con resumen
Nair NP, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, Connolly M, Bereznicki LR. Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf 2017;40:597-606. [Ref.ID 101969]
13. Cita con resumen
Gedeborg R, Svennblad B, Holm L, Sjögren H, Bardage C, Personne M, Sjöberg G, Feltelius N, Zethelius B. Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry study. Pharmacoepidemiol Drug Saf 2017;26:518-27. [Ref.ID 101958]
14. Cita con resumen
Damen NL, Baines R, Wagner C, Langelaan M. Medication-related adverse events during hospitalization: a retrospective patient record review study in The Netherlands. Pharmacoepidemiol Drug Saf 2017;26:32-9. [Ref.ID 101947]
15. Cita con resumen
Shin J-Y, Eberg M, Enrst P, Filion KB. Statin potency and the risk of hospitalization for community-acquired pneumonia. Br J Clin Pharmacol 2017;83:1319-27. [Ref.ID 101943]
16. Cita con resumen
Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. Pharmacoepidemiol Drug Saf 2017;26:635-41. [Ref.ID 101626]
18. Cita con resumen
Huizinga P, Kluytmans– van den Bergh M, Willemsen I, van ‘t Veer N, Kluytmans J. Proton pump inhibitor use is associated with extended-spectrum ß-lactamase–producing Enterobacteriaceae rectal carriage at hospital admission: a cross-sectional study . Clin Infect Dis 2016;64:361-3. [Ref.ID 101382]
19.Enlace a cita original
Anónimo. Sacubitril/valsartan for chronic heart failure. Australian Prescriber 2016;39:221. [Ref.ID 101024]
20.Tiene citas relacionadas Cita con resumen
Kessler C, Ward MJ, McNaughton CD. Reducing adverse drug events: the need to rethink outpatient prescribing. JAMA 2016;316:2092-3. [Ref.ID 100974]
Seleccionar todas
 
 1 a 20 de 468 siguiente >>